Governor of Enugu State, Dr Peter Mbah, has commissioned Anchorage Pharmaceutical Industries Limited, a multi-billion-naira pharmaceutical plant located in Trans-Ekulu, Enugu, to strengthen local drug production, create jobs and improve healthcare delivery.
Speaking at the commissioning ceremony held on Thursday, October 22,2026, Governor Mbah described the facility as more than a business investment, saying it represented a strategic contribution to public health, industrial development and the future of young people in the state.
He congratulated the founder of the company, Rear- Admiral Allison Mmadueke Retd’, board and management team, noting that establishing a manufacturing enterprise required substantial commitment, investment and confidence in the state’s economic prospects.
The said the company would create jobs, provide internship opportunities and facilitate skills transfer, while supporting healthcare delivery across Enugu State.
Mbah disclosed that the state government would explore commercial partnerships with Anchorage for the supply of medicines to its central medical stores and primary healthcare facilities.
He noted that his administration was constructing 260 Type-2 primary healthcare centres across the state, stressing that the facilities would require a reliable supply of essential medicines to function effectively.
“We are interested in made-in-Enugu, and that’s what you’re doing here,” the governor said.
Gov Mbah reaffirmed his administration’s commitment to working with private enterprises, emphasising that government support for businesses must go beyond providing an enabling environment to developing practical partnerships that promote investment and economic growth.
.
He added that private capital remained central to his administration’s development strategy, stressing the need to create opportunities for skilled young people to build their careers in Enugu rather than seek employment elsewhere.
The governor assured investors of continued government support through policies and infrastructure aimed at improving the business environment, attracting investments and enhancing returns on investment.
Speaking, the Chairman of the company’s Board of Directors, Rear Admiral Allison Madueke (retd.), commended Mbah for creating an investment-friendly environment in Enugu State, describing Anchorage as a legacy project conceived to generate employment, develop local talent and drive economic growth.
Earlier, Madueke said Anchorage was the practical expression of his longstanding conviction that private enterprise could create jobs, expand economic opportunities and improve prosperity.
The former Chief of Naval Staff and former military governor of the old Anambra and Imo States expressed confidence that the company would contribute to the development of Enugu State, the South-East and Nigeria.
He said the company would prioritise product quality, patient safety, regulatory compliance and sound corporate governance, while acknowledging the critical role of the National Agency for Food and Drug Administration and Control (NAFDAC) in safeguarding public health.
Anchorage phamarcueticall Ltd
Madueke thanked Mbah for commissioning the facility, commending his administration for developing business-friendly infrastructure and creating an environment capable of attracting private investment.
In his closing remarks, the Managing Director of Anchorage Pharmaceutical Industries Limited, Engr. Chima Madueke, said the company was founded on the principles of quality and wellness, encapsulated in its slogan, “Anchored in Quality, Committed to Wellness.”
He disclosed that the company had obtained the necessary approvals and clearances from NAFDAC and the Pharmaceutical Society of Nigeria (PSN), reaffirming its commitment to quality assurance and regulatory compliance.
According to him, Anchorage would contribute to efforts to tackle fake and substandard medicines in Nigeria by prioritising the production and distribution of quality pharmaceutical products.
He added that the company was open to supplying medicines directly to hospitals, healthcare institutions and pharmacies to ensure wider access to its products.
The facility is expected to boost domestic pharmaceutical manufacturing, provide employment opportunities for young people and contribute to the fight against fake and substandard medicines in Nigeria.
